Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > XRAY PLUS RU KILLS LUNG CANCER

<< Previous

Bullboard Posts

Next >>

Comment by CancerSlayeron Jun 20, 2024 12:08pm

122 Views

Post# 36098087

RE:RE:RE:XRAY PLUS RU KILLS LUNG CANCER

Tarbaby wrote: Thsnks Cancerslayer..
Yes it appears that the XRU treatment would be very simple..compared to present methods. Injection of RU plus a few xrays.

Also why not try XRU on mouse implants of prostate cancer also. If it cured that...WOW.
Tharalase is sitting on a potential gold mine.

A few of us bloggers could pool our money and pay for the mouse studies.

Yep...for me personally (elder male), I'd go straight for the prostate. Throw in some lung just in case of metastasis. As for pooling monies, I got plenty of free mice in my back yard.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season